Table 1. Clinicopathological characteristics of 219 patients diagnosed with endometrioid endometrial adenocarcinoma (EEC).
| Characteristics | Patients (%) |
|---|---|
| Median age (years) | 63 |
| Variation | 42–89 |
| Hypertension | |
| Yes | 153 (69.9) |
| No | 66 (30.1) |
| Diabetes | |
| Yes | 55 (25.1) |
| No | 164 (74.9) |
| Heart diseases | |
| Yes | 17 (7.8) |
| No | 202 (92.2) |
| Obesity | |
| Yes | 111 (50.7) |
| No | 106 (48.4) |
| Overweight | |
| Yes | 71 (32.4) |
| No | 146 (66.7) |
| Nulliparity | |
| Yes | 29 (13.2) |
| No | 185 (84.5) |
| Contraceptive use | |
| Yes | 79 (36.1) |
| No | 113 (51.6) |
| Exogenous estrogen therapy | |
| Yes | 15 (6.8) |
| No | 175 (79.9) |
| FIGO stage | |
| IA | 113 (51.6) |
| IB | 44 (20.1) |
| II | 27 (12.3) |
| III | 29 (13.2) |
| IV | 6 (2.7) |
| Histological grade | |
| Well differentiated (G1) | 67 (30.6) |
| Moderate differentiated (G2) | 91 (41.6) |
| Poorly differentiated (G3) | 61 (27.9) |
| Recurrence | |
| Yes | 29 (13.2) |
| No | 190 (86.8) |